Salesforce

Measure Paper - CMS 2025 Measure 136v14 for NextGen Office

« Go Back

Information

 
Application Version
Program/Measure Year
Build Version
Document Summary
DomainCommunity/Population Health 
Measure Name CMS 136 v14: Follow-Up Care for Children Prescribed ADHD Medication (ADD)
 Description  Percentage of children 6-12 years of age and newly dispensed a medication for attention-deficit/hyperactivity disorder (ADHD) who had appropriate follow-up care. Two rates are reported.  
  • Percentage of children who had one follow-up visit with a practitioner with prescribing authority during the 30-day Initiation Phase.
  • Percentage of children who remained on ADHD medication for at least 210 days and who, in addition to the visit in the Initiation Phase, had at least two additional follow-up visits with a practitioner within 270 days (9 months) after the Initiation Phase ended.
In the Attachments section of the article, locate the measure paper for NextGen Healthcare Solution.
Attachment 1NextGen Health Quality Measure

 

Attachment 1
Attachment 2
Attachment 3
Attachment 4
Attachment 5
KeywordseCQM CMS136 "attention-deficit/hyperactivity disorder" ADHD medications meds drugs children ADD MIPS
TitleMeasure Paper - CMS 2025 Measure 136v14 for NextGen Office
URL NameCMS136

Powered by